The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers, including Professor Matthew Walker (UCL Queen Square Institute of Neurology), has been successfully completed.
Read: Mail Online, More: UCL News
Close
